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Background: Primary infection with TORCH complex [Toxo-
plasma, Rubella, Cytomegalovirus (CMV), and Herpes simplex
virus II (HSV-II)] together with Parvovirus B19 (B19) in pregnant
women can lead to adverse outcome which are initially inappar-
ent or asymptomatic and thus difﬁcult to diagnose on clinical
grounds. The present study was conducted to estimate the fre-
quency of Toxoplasma, Rubella, Cytomegalovirus, Herpes Simplex
Virus (TORCH) & Parvovirus B19 (B19) infections among pregnant
females with Bad Obstetric History(BOH) and/or antecedent preg-
nancy complications.
Methods&Materials:Overaperiodofoneyear100women(20-
35 years) with BOH and/or antecedent pregnancy complications
were studied. Sera were analyzed for IgM antibodies for B19 and
TORCH agents by ELISA.
Results: Out of 100 high-risk pregnant women, 82 (82%) had
BOH while 18 (18%) had underlying complications including oligo-
hydramnios (n =8) and intrauterine growth restriction (n=10).
Adverse outcomes occurred in 56 (56%) high-risk cases resulting
in 28 preterm stillbirths, nine abortions, six newborns with con-
genital malformations, nine full-term stillbirths and four cases of
non-immunehydrops fetalis .Of the100 samples screened, 75 (75%)
cases were seropositive for TORCH & B19 alone or in combination.
IgMpositivity to T. gondii, rubella, cytomegalovirus, herpes simplex
virus and B19 virus was 16.7%, 8%, 58.8%, 2.2% and 14.6% respec-
tively. B19 infection caused NIHF in four cases and cardiac anomaly
in two.
Conclusion:WomenwithBOHand/or pregnancy complications
had a high frequency of TORCH and parvovirus B19 infections caus-
ing fetal wastage, IUGR, NIHF and congenital malformations. So
screening and early diagnosis for TORCH infection in females can
help in adequate management of these cases and prevent dreadful
pregnancy outcomes.
http://dx.doi.org/10.1016/j.ijid.2014.03.1066
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Correlation of fulminant hepatitis B, HBeAg
start-codon depletions and escape mutations in
the 2nd loop of the HBsAg a-determinant
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Background: Most of the 600.000 fatalities caused by Hepatitis
B Virus (HBV) annually derive from sequelae of chronic infection.
Chroniﬁcation is strongly and inversely correlated with symptoms
ofhepatitiswithcases leading tochroniﬁcationusuallynot showing
symptoms and cases with symptoms mostly leading to cure within
6 months. Key to this phenomenon is a strong immune response
to viral components, which leads to elimination of infected hepa-
tocytes and thereby causes clinical symptoms. Because of this,
one of the most promising therapeutic approaches is to elicit a T-
cell response against viral proteins by therapeutic vaccination of
chronic Hepatitis B patients.
Methods & Materials: To understand the factors triggering a
solid T-cell response, we thoroughly analyzed cases of acute and
chronic Hepatitis B presenting in our clinic. These included 13
chronic and 7 acute and symptomatic cases of which 2 had a ful-
minant course with highly impaired liver functions.
Results: Strikingly, similar mutations were observed in both
virus strains causing fulminanthepatitis, eachharboringamutation
depleting the HBeAg start codon as well as HBsAg escape muta-
tions situated in the 2nd loop of the a-determinant (S143L; S143M).
Correlating to this, an intense CD8 T-cell response predominantly
targeting HBsAg was measured via intra-cellular cytokine stain-
ing. No such mutants were detected in asymptomatic and chronic
hepatitis B patients.
Conclusion: While the loss of HBeAg has been associated with
fulminant hepatitis for a long time, HBsAg escape mutants have
mostly beendescribed in the context of chronic infections e.g.when
negative HBsAg tests in occult infections prompted the molecu-
lar analysis of these strains or after HBV variants escaped vaccine
induced or passively administered anti-HBs antibodies. Since these
settings involve escape mainly from antibodies, studies analyzing
the antigenicity of HBsAg escape mutants focused on their reac-
tivity to antibodies and largely neglected the role of the cellular
response. The accumulationof thesemutants in fulminant hepatitis
in associationwith the strongCD8 response againstHBsAg epitopes
suggest a link. We are currently further characterizing these clones
in-vivo using an Adenovirus-based HBV-infection model.
http://dx.doi.org/10.1016/j.ijid.2014.03.1067
